FDA approves non-drug treatment of depression using magnetic pulses

Alaric DeArment

10/9/2008

WASHINGTON The Food and Drug Administration has approved a treatment for depression that uses magnetic stimulation, maker Neuronetics announced Wednesday.

The Malvern, Pa.-based medical device company said it will introduce the treatment, NeuroStar TMS Therapy, in a small number of treatment centers.

The device delivers a magnetic pulse to the area of the brain linked to depression with a strength equal to that of an MRI scan. The procedure will take 40 minutes each day for four to six weeks.

Walgreens buyout reportedly could result in three divisions

Walgreens’ three core segments—U.S. pharmacy retailer Walgreens, U.K.-based Boots and specialty unit Shields Health Solutions—could become three independent divisions, per a report.

Ulta Beauty sets date for experiential beauty event

Ulta Beauty World will take place on April 26 in San Antonio, Texas.

CVS Health to open smaller format stores

Each location will average less than 5,000 square feet and will feature a full-service pharmacy with limited over-the-counter products available for purchase.

Walgreens reportedly close to roughly $10B deal to go private

The deal could be finalized by Thursday, per a WSJ report.

Costco to raise hourly pay, reaches tentative agreement with union

Costco also is adding vacation time for new employees during their first year and giving workers with 30 years of employment an additional week of time off, per a CNN report.